দেশ: অস্ট্রেলিয়া
ভাষা: ইংরেজি
সূত্র: Department of Health (Therapeutic Goods Administration)
glycopyrronium bromide, Quantity: 63 microgram (Equivalent: glycopyrronium, Qty 50 microgram); mometasone furoate, Quantity: 80 microgram; indacaterol acetate, Quantity: 173 microgram (Equivalent: indacaterol, Qty 150 microgram)
Grand Medical Pty Ltd
Capsule, hard
Excipient Ingredients: lactose monohydrate; magnesium stearate
Inhalation
10 capsules + 1 inhaler (sample and commercial packs), 30 capsules + 1 inhaler
(S4) Prescription Only Medicine
Zimbus Breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long-acting beta2-agonist and an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
Visual Identification: White to practically white powder in a hard hypromellose capsule of size 3 with green transparent cap and uncoloured transparent body with a white marking on the cap and 'IGM150-50-80' printed in black on the body; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure
Registered
2022-07-07